Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study

BACKGROUND: Persons living with human immunodeficiency virus are an underserved population for evidence-based cancer treatment. Paclitaxel and carboplatin (PCb) is an active regimen against a variety of solid tumors, including several seen in excess in patients with HIV infection. We performed a pil...

Descripción completa

Detalles Bibliográficos
Autores principales: Haigentz, Missak, Moore, Page, Bimali, Milan, Cooley, Timothy, Sparano, Joseph, Rudek, Michelle, Ratner, Lee, Henry, David, Ramos, Juan, Deeken, John, Rubinstein, Paul, Chiao, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355812/
https://www.ncbi.nlm.nih.gov/pubmed/35429391
http://dx.doi.org/10.1093/oncolo/oyac004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355812/
https://www.ncbi.nlm.nih.gov/pubmed/35429391
http://dx.doi.org/10.1093/oncolo/oyac004

Ejemplares similares